SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuit, Inc. engages in the provision of business and financial management solutions. It operates through the following segments: Small Business and Self-Employed, Consumer, Credit Karma, and ProTax. The Small Business and Self-Employed segment offers QuickBooks financial and business management online services and desktop software, payroll solutions, payment processing solutions, and financing for small businesses. The Consumer segment includes do-it-yourself and assisted TurboTax income tax preparation products and services. The Credit Karma segment serves consumers with a personal finance platform that provides personalized recommendations of credit cards, home, auto and personal loans, and insurance products, and online savings and checking accounts. The ProTax segment refers to the professional accountants in the U.S. and Canada, who are essential to both small business success and tax preparation and filing. The company was founded by Scott D. Cook and Thomas A. Proulx in March 1983 and is headquartered in Mountain View, CA.

Intuit Inc

Intuit's post-earnings selloff is driven by strong quarterly results being overshadowed by a weak full-year guidance, with community focus on the switch to include stock-based compensation and ongoing fears that AI threatens TurboTax and DIY tax prep. Bulls argue the drop is overdone, while bears point to slowing growth and competitive pressure.

Dick's Sporting Goods, Inc. engages in the retailing of an extensive assortment of authentic sports equipment, apparel, footwear, and accessories. It also offers its products both online and through mobile applications. The company was founded by Richard T. Stack in 1948 and is headquartered in Coraopolis, PA.

Dicks Sporting Goods, Inc.

DKS is trending after a brutal post-earnings selloff triggered by weaker-than-expected results, guided-down full-year outlook, and ongoing drag from the Foot Locker acquisition. Community chatter is sharply split between dip buyers calling it a massive overreaction and shorts expect further downside, with many focusing on the Foot Locker deal as the root problem.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Retail traders are piling into CRML as it leads a strong rare-earth/critical minerals sector move, with the community spotlighting heavy volume, scarce shares, the revised European Lithium merger terms, and a building short-squeeze narrative.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Community buzz centers on founder Patrick Soon-Shiong teasing a trial combining targeted radiation with an IL-15/Anktiva immune approach, fueling speculation about the SHINE Lu-177 supply connection and a broader BioShield push. Retail traders are also weighing the heavy short interest, catalysts like label expansions and pipeline updates, and the recent move back toward $8 as a key battleground.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

ZM is in focus after its quarterly earnings and guidance landed with mixed sentiment, as a stronger print was outweighed by softer near-term guidance and bearish options flow. The community sees the company's Anthropic investment and AI optionality as possible offsets that could eventually re-risk the story, but traders are debating whether the move is a dip buy or a technical breakdown.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is trending as traders jockey ahead of its quarterly earnings, with many debating whether the recent pullback and stretched valuation leave more downside or set up a bounce. Community chatter also centers on the CTO departure, insider selling, and broader AI-driven cybersecurity demand.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

ONON is trending after a sharp selloff tied to disappointing guidance and broader weakness across athletic-apparel retailers, with peers like Nike and Dick's Sporting Goods also under pressure. The community is split between bulls highlighting strong margins, DTC growth, and insider buying, and bears pointing to valuation concerns and softer consumer demand.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

HELP is trending as retail traders rally around the psychedelic sector, energized by the new CEO's track record and the fully enrolled Phase 3 trial on track for a Q4 readout. The conversation centers on buyout speculation, dilution fears, and the stock's deep-value positioning relative to higher-valued peers.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnival is trending as mixed U.S.-Iran ceasefire signals and Strait of Hormuz uncertainty drive sharp swings in oil prices that traders immediately map to cruise fuel costs. Community debate centers on whether the move is algorithmic manipulation or a buying opportunity for a low-P/E travel play ahead of major catalysts, with swing traders cyclically buying dips and fading rips.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing heavy attention as the oil market gets slammed between fresh Strait of Hormuz deal/reopening headlines and growing accusations that the administration is deliberately jawboning crude prices lower. Traders are split between calling the drop a manipulated fake-out and positioning for a severe supply shortfall, with the community also citing continued tanker missile incidents and multiweek inventories as proof the geopolitical risk premium remains unresolved.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Coherus Oncology (CHRS) Reports Q2 Loss, Misses Revenue Estimates

Coherus Oncology (CHRS) delivered earnings and revenue surprises of -337.50% and -45.57%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Solid Tumor Treatment Race Heats Up as Multi-Billion-Dollar Oncology Market Enters High-Growth Phase

Solid Tumor Treatment Race Heats Up as Multi-Billion-Dollar Oncology Market Enters High-Growth Phase Solid Tumor Treatment Race Heats Up as Multi-Billion-Dollar Oncology Market Enters High-Growth...

Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates

Coherus Oncology (CHRS) delivered earnings and revenue surprises of -38.89% and -14.37%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Are Medical Stocks Lagging  AnaptysBio (ANAB) This Year?

Here is how AnaptysBio, Inc. (ANAB) and Coherus Oncology (CHRS) have performed compared to their sector so far this year.

Coherus Oncology (CHRS) Projected to Post Quarterly Earnings on Monday

Coherus Oncology (NASDAQ:CHRS) will be releasing its Q1 2026 earnings after the market closes on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-coherus-biosciences-inc-stock...

Coherus Oncology (NASDAQ:CHRS) Stock Price Crosses Above 200-Day Moving Average   - Here's Why

Coherus Oncology (NASDAQ:CHRS) Share Price Crosses Above 200-Day Moving Average - What's Next...

Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?

Here is how Brookdale Senior Living (BKD) and Coherus Oncology (CHRS) have performed compared to their sector so far this year.

Coherus Oncology (NASDAQ:CHRS) Stock Price Passes Above Two Hundred Day Moving Average   - Time to Sell?

Coherus Oncology (NASDAQ:CHRS) Shares Cross Above Two Hundred Day Moving Average - Should You Sell...

Coherus Oncology, Inc. (NASDAQ:CHRS) Given Average Recommendation of "Hold" by Brokerages

Coherus Oncology, Inc. (NASDAQ:CHRS - Get Free Report) has earned an average recommendation of "Hold" from the five research firms that are presently covering the firm, Marketbeat reports. One...

Coherus Oncology (NASDAQ:CHRS) Stock Price Passes Above 200 Day Moving Average   - Should You Sell?

Coherus Oncology (NASDAQ:CHRS) Share Price Crosses Above 200 Day Moving Average - Time to Sell...

Coherus Oncology, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Coherus Oncology Inc.

Bullish Sentiment

Rallies more than 5%

Modest gain (0-5%)

Modest decline (0-5%)

Drops more than 5%

Nvidia ($NVDA) reports earnings Wednesday, August 26, with options markets pricing in a roughly 5-7% post-earnings move. How do you think Nvidia's stock reacts to earnings? Vote and explain your reasoning in the comments.

Nvidia ($NVDA) reports earnings Wednesday, with options markets pricing in a 5-7% move. How do you think the stock reacts?

Stocktwits

) reports earnings Wednesday, with options markets pricing in a 5-7% move. How do you think the stock reacts?

Current Price	$1.37
Prev Close	$1.36
Open	$1.36
Dividend Yield	0.00%
50-Day Moving Average	$1.41
Beta	1.84
Avg. Volume	701,121.88
PE Ratio	-1.33

52-Week High	$2.62
52-Week Low	$1.09
Market Capitalization	$210.12M
EPS (Annual)	-$1.45
Price to Book	3.45
Revenue Per Employee	$286,884.35

Feed

News

Sentiment

Earnings

Fundamentals

Info